Results 171 to 180 of about 22,306,541 (256)
Safety of BromAc<sup>®</sup> with Mitomycin C during hyperthermic intraperitoneal chemotherapy (HIPEC): a preclinical study. [PDF]
Mekkawy AH +9 more
europepmc +1 more source
Scrotal wall necrosis after hipec using mitomycin-c: Case report and review of the literature. [PDF]
El Halabieh MA +5 more
europepmc +1 more source
Comparing the Effects of Mitomycin-C and Triamcinolone-Acetonide Injections on Hypertrophic Scars and Keloids in Burn Patients. [PDF]
Jafarzadeh J +4 more
europepmc +1 more source
RETRACTION: Effect of Mitomycin C and 5-Fluorouracil on Wound Healing in Patients Undergoing Glaucoma Surgery: A Meta-Analysis. [PDF]
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Intermediate Outcomes of a Novel Standalone Ab Externo SIBS Microshunt With Mitomycin C
American Journal of Ophthalmology, 2020PURPOSE To determine the efficacy, risk factors for failure, and adverse events of a standalone novel ab-externo SIBS microshunt with mitomycin C (MMC) during 1-year follow-up. DESIGN Retrospective, interventional case series.
Matthew B Schlenker +2 more
exaly +2 more sources
The Laryngoscope, 2020
Topical mitomycin‐C (MMC) application is a commonly accepted adjuvant therapy in the surgical treatment for laryngotracheal stenosis (LTS). However, the efficacy of MMC has not been examined in a prospective, randomized clinical trial in humans. We aimed
K. Yung, Joseph Chang, M. Courey
semanticscholar +1 more source
Topical mitomycin‐C (MMC) application is a commonly accepted adjuvant therapy in the surgical treatment for laryngotracheal stenosis (LTS). However, the efficacy of MMC has not been examined in a prospective, randomized clinical trial in humans. We aimed
K. Yung, Joseph Chang, M. Courey
semanticscholar +1 more source
Cancer chemotherapy and biological response modifiers, 1990
The mitomycins are antitumor antibiotics that are under investigation now for more than 30 years. Mitomycin C (MMC) is the best investigated subtype. It serves as a prototype for drugs with bioreductive alkylation, which is a unique feature of this class. MMC is mainly active under anaerobic circumstances.
J, Verweij, H M, Pinedo
+9 more sources
The mitomycins are antitumor antibiotics that are under investigation now for more than 30 years. Mitomycin C (MMC) is the best investigated subtype. It serves as a prototype for drugs with bioreductive alkylation, which is a unique feature of this class. MMC is mainly active under anaerobic circumstances.
J, Verweij, H M, Pinedo
+9 more sources
Mitomycin C extravasation injuries
Cancer, 1983Mitomycin C extravasation produces a chronic painful ulceration similar to that of adriamycin. Pain marks the extravasation of this chemotherapeutic agent when it occurs. A complaint of pain during mitomycin administration should prompt immediate cessation of infusion and regular frequent follow-up.
L C, Argenta, E K, Manders
openaire +2 more sources

